General
Preferred name
Daptomycin
Synonyms
LY146032 ()
P&D ID
PD012318
CAS
103060-53-3
Tags
available
drug
Approved by
PMDA
FDA
First approval
2003
Drug Status
approved
investigational
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Cell lines
0
Organisms
1
Compound Sets
9
Cayman Chemical Bioactives
15615
Drug Repurposing Hub
DrugBank
DB00080
DrugBank Approved Drugs
DB00080
DrugCentral
783
DrugCentral Approved Drugs
783
MedChem Express Bioactive Compound Library
HY-B0108
NCATS Inxight Approved Drugs
NWQ5N31VKK
ReFrame library
External IDs
17
Properties
(calculated by RDKit )
Molecular Weight
1619.71
Hydrogen Bond Acceptors
24
Hydrogen Bond Donors
22
Rotatable Bonds
35
Ring Count
4
Aromatic Ring Count
3
cLogP
-5.62
TPSA
702.02
Fraction CSP3
0.53
Chiral centers
13.0
Largest ring
31.0
QED
0.01
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Indication
skin infections, endocarditis
MOA
bacterial cell wall synthesis inhibitor
Target
antibiotic
Bacterial
Pathway
Anti-infection
Source data